Pediatric parapneumonic empyema: Risk factors, clinical characteristics, microbiology, and management

Pediatric Emergency Care

Volumn 29, Issue 4, 2013, Pages 425-429

  Grisaru Soen, Galia ^a   Eisenstadt, Michal ^b   Paret, Gideon ^c   Schwartz, David ^a   Keller, Nathan ^d   Nagar, Hagit ^a   Reif, Shimon ^e  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c Safra Children's Hospital   (Israel)

^d ARIEL UNIVERSITY   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

empyema; prolonged fever; S. pneumoniae; video assisted thoracoscop

Indexed keywords

AMOXICILLIN; ANTIPYRETIC AGENT; C REACTIVE PROTEIN; METICILLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; SALBUTAMOL; SALBUTAMOL SULFATE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; CASE CONTROL STUDY; CHEST TUBE; CHILD; CHILDHOOD DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DECORTICATION; DISEASE COURSE; DYSPNEA; EMPYEMA; FEMALE; FEVER; FIBRINOLYSIS; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; IMAGING AND DISPLAY; INFANT; INHALATION; LUNG ABSCESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; OUTCOME ASSESSMENT; PATHOGENESIS; PHYSICAL EXAMINATION; PLEURA EFFUSION; PLEURA FLUID; PNEUMATOCELE; PNEUMOTHORAX; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEROTYPE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; TERTIARY HEALTH CARE; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; EMPYEMA, PLEURAL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; ISRAEL; LENGTH OF STAY; MALE; PNEUMOCOCCAL VACCINES; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 84876418770     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0b013e318289e810     Document Type: Article

References (19)

1. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med. 1980;69:507-512.
2. Freij BJ, Kusmiesz H, Nelson JD, et al. Parapneumonic effusions and empyema in hospitalized children. A retrospective review of 227 cases. Pediatr Infect Dis. 1984;3:578-591.
3. Chonmaitree T, Powell KR. Parapneumonic pleural effusion and empyema in children. Review of a 19-year experience1962-1980. Clin Pediatr. 1983;22:414-419.
4. Playfor S, Smyth AR, Stewart RJ. Increase in incidence of childhood empyema. Thorax. 1997;52:932.
5. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: Risk factors and microbiological associations. Clin Infect Dis. 2002;34:434-440.
6. Wexler ID, Knoll S, Picard E, et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol. 2006;41:726-734.
7. Picard E, Joseph L, Goldberg S, et al. Predictive factors of morbidity in childhood parapneumonic effusion-associated pneumonia: A retrospective study. Pediatr Infect Dis J. 2010;29:840-843.
8. Byington CL, Korgenski K, Daly J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006;25:250-254.
9. Hsieh YC, Hsueh PR, Lu CY, et al. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis. 2004;38:830-835.
10. Lin CJ, Chen PY, Huang FL, et al. Radiographic, clinical and prognostic features of complicated and uncomplicated community acquired lobar pneumonia in children. J Microbiol Immunol Infect. 2006;39:489-495.
11. De Britto MC, Da Conceicao S, Do Carmo Menezes DM, et al. Clinical profile of pleural empyema and associated factors with prolonged hospitalization in paediatric tertiary centre in Angola, Luanda. Trop Doct. 2008;38:118-120.
12. Lambert CC, Hunter RL. Low levels of unsaturated transferrin as a predictor of survival in pneumococcal pneumonia. Ann Clin Lab Sci. 1990;20:140-146.
13. Laupland KB, Davies HD, Kellner JD, et al. Predictors and outcome of admission for invasive Streptococcus pneumoniae infections at a Canadian children's hospital. Clin Infect Dis. 1998;27:597-602.
14. Proesmans M, De Boeck K. Clinical practice: Treatment of childhood empyema. Eur J Pediatr. 2009;168:639-645.
15. Jaffé A, Balfour-Lynn IM. Management of empyema in children. Pediatr Pulmonol. 2005;40:148-156.
16. Sonnappa S, Cohen G, Owens CM, et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med. 2006;174:221-227.
17. Balfour-Lynn IM, Abrahamson E, Cohen G, et al. British Thoracic Society Guidelines for the management of pleural infection in children. Thorax. 2005;60(suppl 1):i1-i21.
18. Avansino JR, Goldman B, Sawin RS, et al. Primary operative versus nonoperative therapy for pediatric empyema: A meta-analysis. Pediatrics. 2005;115:1652-1659.
19. St. Petera SD, Tsaoa K, Harrison C, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: A prospective, randomized trial. Pediatr Surg. 2009;44:106-111.